Search

Search results

73 results found

Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX: bone microarchitecture international consortium (BoMIC) prospective cohorts.

Sarfati, Marine, Roland Chapurlat, Alyssa B Dufour, Elisabeth Sornay-Rendu, Blandine Merle, Steven K Boyd, Danielle E Whittier, et al. 2024. “Short-Term Risk of Fracture Is Increased by Deficits in Cortical and Trabecular Bone Microarchitecture Independent of DXA BMD and FRAX: Bone Microarchitecture International Consortium (BoMIC) Prospective Cohorts.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research.

Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project.

Schini, Marian, Tatiane Vilaca, Li-Yung Lui, Susan K Ewing, Austin Thompson, Eric Vittinghoff, Douglas C Bauer, Mary L Bouxsein, Dennis M Black, and Richard Eastell. 2024. “Pre-Treatment Bone Mineral Density and the Benefit of Pharmacologic Treatment on Fracture Risk and BMD Change: Analysis from the FNIH-ASBMR SABRE Project.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 39 (7): 867-76.

The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.

Ramchand, Sabashini K, Natalie L David, Hang Lee, Michael Bruce, Mary L Bouxsein, Joy N Tsai, and Benjamin Z Leder. 2023. “The Effect of Zoledronic Acid on Bone Microarchitecture and Strength After Denosumab and Teriparatide Administration: DATA-HD Study Extension.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 38 (1): 26-34.